| Literature DB >> 35224662 |
Isabelle N Tostivint1, Rita G Araman2,3, Vincent Castiglione4, Rana Alkouri5, Rosa Vargas-Poussou6, Pierre Conort7, Rachida Inaoui8, Marie-Paule Dousseaux9, Sihem Merazga2, Ziad Lalmi2, Imane Chaoui2, Laurence Pieroni5, Gilbert Deray2, Corinne Isnard-Bagnis2, Hassan Izzedine10.
Abstract
Genetic renal phosphate leak is one of the rare disorders in recurrent stone formers with absorptive hypercalciuria. Diagnosis and appropriate management may change the life of patients. To provide answers on how and when to make the diagnosis of genetic renal phosphate leak and how medical management prevents the recurrences and changes patients' life, we conducted a retrospective study including nine patients with recurrent nephrolithiasis and a confirmed genetic mutation of a phosphate transporter between 2008 and 2019 in our multidisciplinary center at the Pitié Salpetriere Hospital, Paris, France. We compared the number and the annual rate of urological intervention before and after the diagnosis and management using the Wilcoxon test. A qualitative survey was done to evaluate the quality of life of patients. A total of 9 patients were included in this study. Patient baseline characteristics and elements supporting the diagnosis are described. We showed an effective decrease in urological intervention number (p = 0.0078) and annual rate (p = 0.0117) after the diagnosis and the appropriate management, and an improvement in the patients' quality of life. The diagnosis and the appropriate management of genetic renal phosphate leak disorder improve the quality of life by preventing stone recurrence and decreasing the number of surgical intervention.Entities:
Keywords: Absorptive hypercalciuria; Genetic disease; Kidney stone; Prevention; Prognosis; Renal phosphate leak; Treatment; Tubular phosphate transporter
Mesh:
Substances:
Year: 2022 PMID: 35224662 DOI: 10.1007/s00240-022-01316-3
Source DB: PubMed Journal: Urolithiasis ISSN: 2194-7228 Impact factor: 3.436